Study,Effect Size,Effect Type,Lower CI,Upper CI,Population,Authors,Reference,SE
Romelli M et al.,0.76,OR,0.67,0.87,Patients,"Romelli M, Gnagnarella P, Gaeta A, Serrano D, Ermini I, Cavalcabo' NDB, Saieva C, Iadevaia S, Gandini S, Caini S",Coffee and tea intake and survival of cancer patients: a systematic review and meta-analysis.,0.05102040816326529
Wang H et al.,1.54,OR,1.33,1.78,General,"Wang H, Ma K, Shan M, Zhang G",Assessing the genetic estimates of the association between plasma caffeine and cancer risk through Mendelian randomization.,0.11479591836734693
Tanha K et al.,1.077,OR,1.032,1.124,General,"Tanha K, Mottaghi A, Nojomi M, Moradi M, Rajabzadeh R, Lotfi S, Janani L",Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses.,0.023469387755102062
Li Y et al.,0.95,RR,0.92,0.99,General,"Li Y, Ma L",The association between coffee intake and breast cancer risk: a meta-analysis and dose-response analysis using recent evidence.,0.017857142857142846
Ong JS et al.,0.99,ODDS RATIO,0.94,1.08,General,"Ong JS, Law MH, An J, Han X, Gharahkhani P, Whiteman DC, Neale RE, MacGregor S",Association between coffee consumption and overall risk of being diagnosed with or dying from cancer among >300 000 UK Biobank participants in a large-scale Mendelian randomization study.,0.03571428571428575
